Moreover, two vitamin D analogs, EB1089 and QW-1624F2, reduced breast cancer cells and breast cancer stem-like cells by blocking them in G1/S cell cycle phase and by inducing p21 expression [141]. The gene discussed is CDKN1A; the disease is breast carcinoma.